Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Médetone vs No BS RX

By GLP-1 ScorecardUpdated

Médetone
Site position #425

Lower score

No BS RXFactor scores not reassessed.
Site position #23

Higher score

Score comparison

No BS RX has the higher recorded score — 82.8/100 to 57.6/100.

No BS RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. No BS RX publishes separate prices for standard compounded, low-dose and brand-name programs.

Before you choose

Before comparing the headline prices, the Médetone review and the No BS RX review set out what each semaglutide figure in the table below covers, including whether the medication is a brand-name product billed by a pharmacy. Brand-name and compounded prices are different products, so set like against like before treating either one as cheaper.

If neither one fits, Médetone vs Sesame Care and MedLeanRx vs No BS RX compare each of them with another graded program, and the list of alternatives to Médetone ranks the programs closest to Médetone on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the Collective review covers one graded close to these two, at 71.6/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueNo BS RX +61
31
92
Dose & formulationNo BS RX +7
83
90
Clinical oversightNo BS RX +12
60
72
Labs & monitoringNo BS RX +17
51
68
FulfillmentNo BS RX +25
69
94
Contract termsNo BS RX +7
67
74
Médetone · top barNo BS RX · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricMédetoneNo BS RX
WeighScore57.6/10082.8/100
GradeCB−
Site position#425#23
SemaglutideBrand Wegovy from $199/mo, Wegovy pill from $149/mo by dose (plus required membership: $29 first month, then $69/mo)$149/mo advertised for standard compounded injection; low-dose priced separately
TirzepatideBrand Zepbound from $299/mo by dose (plus required membership: $29 first month, then $69/mo)$225/mo advertised for standard compounded injection; low-dose priced separately
CoverageNot publishedConfirm program availability for your state
Brand-name accessYesYes
Oral / sublingualYesYes
Médetone

Site position #425 · C

Strengths

  • Publishes a cash price for every brand-name dose, including the Wegovy pill and Foundayo
  • Fills prescriptions through its own licensed pharmacy, which it names
  • Annual membership option for buyers who stay on treatment

What to consider

  • The required membership is billed on top of the medication price
  • Prices rise with each dose step
  • No refund once a physician review has begun
  • The prescribing medical group and states served are not published
No BS RX

Site position #23 · B−

Factor scores not reassessed.

Strengths

  • Displays monthly and prepaid amounts by program
  • Advertises consultation, medication, shipping and messaging in the compounded plans
  • Lists branded Ozempic and Zepbound separately

What to consider

  • The $115 headline applies to low-dose programs
  • Plans renew automatically at the then-current rate
  • Cancellation generally stops future billing without refunding the current period

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard